Advanced Oncotherapy PLC Holding(s) in Company (0754E)
May 03 2017 - 8:29AM
UK Regulatory
TIDMAVO TIDMAV.
RNS Number : 0754E
Advanced Oncotherapy PLC
03 May 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
--------------------------------------------------
1. Identity of the issuer or Advanced Oncotherapy plc
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
----------------------------------------------------------------- --------------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
---------------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
--------------------------------------------------------------------- ----------------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
--------------------------------------------------------------------- ----------------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
--------------------------------------------------------------------- ----------------------------------
An event changing the breakdown of voting rights
:
--------------------------------------------------------------------- ----------------------------------
Other (please
specify):
----------------------------------------------------------- -------- ----------------------------------
3. Full name of person(s) Aviva plc & its subsidiaries
subject to the
notification obligation:
(iii)
------------------------------------------------------------- ------------------------------------------
4. Full name of shareholder(s) Registered Holder:
(if different from 3.):(iv)
Available on Request 7,068*
Chase (GA Group) Nominees
Limited 1,474,892*
HSBC Global Custody Nominee
(UK) Limited 328,573*
*denotes direct interest
------------------------------------------------------------- ------------------------------------------
5. Date of the transaction 28 April 2017
and date on
which the threshold is crossed
or
reached: (v)
------------------------------------------------------------- ------------------------------------------
6. Date on which issuer notified: 2 May 2017
------------------------------------------------------------- ------------------------------------------
7. Threshold(s) that is/are 3% to <3% Change at Direct
crossed or Interest Level (Box 8A)
reached: (vi, vii)
------------------------------------------------------------- ------------------------------------------
8. Notified details:
--------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
--------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after
of to the triggering the triggering transaction
shares transaction
if possible
using
the ISIN
CODE
-------------- ---------------------------- ----------------------------------------------------------------
Number Number Number Number of % of voting
of of of voting rights (x)
Shares Voting shares rights
Rights
-------------- ------------- ------------- ---------- --------------------------- -----------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
-------------- ------------- ------------- ---------- ------------ ------------- ------- --------------
Ordinary
Shares GBP
0.25
**Not Not
GB00BD6SX109 3,247,036 3,247,036 1,810,533 1,810,533 disclosable 2.44% disclosable
------------- ------------- ---------- ------------ ------------- ------- --------------
B: Qualifying Financial Instruments
--------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
--------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument (xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
-------------- ------------- ------------- ------------------------ --------------------------------------
RIGHT TO
RECALL 485,960*
LOANED
SHARES N/A N/A *Direct Interest 0.66%
-------------- ------------- ------------- ------------------------ --------------------------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
-----------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-----------------------------------------------------------------------------------------------
Type of financial Exercise Expiration Exercise/ Number of voting % of voting
instrument price date Conversion rights instrument rights (xix,
(xvii) period refers to xx)
(xviii)
------------------ --------- ----------- ------------ ------------------- ----------------
Nominal Delta
------------------ --------- ----------- ------------ ------------------- -------- ------
Total (A+B+C)
------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------ ----------------------------
2,296,493 3.10%
------------------------ ----------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
----------------------------------------------------------------------
The voting rights are managed and controlled by Aviva
Investors Global Services Limited and Friends Provident
International Limited, with the following chain of controlled
undertakings:-
Aviva Investors Global Services Limited:
* Aviva plc (Parent Company)
* Aviva Group Holdings Limited (wholly owned subsidiary
of Aviva plc)
* Aviva Investors Holdings Limited (wholly owned
subsidiary of Aviva Group Holdings Limited)
* Aviva Investors Global Services Limited (wholly owned
subsidiary of Aviva Investors Holdings Limited)
Friends Provident International Limited:
* Aviva plc (Parent Company)
* Aviva Group Holdings Limited (wholly owned subsidiary
of Aviva plc)
* Friends Provident International Limited (wholly owned
subsidiary of Aviva Group Holdings Limited)
Proxy Voting:
----------------------------------------------------------------------
10. Name of the proxy holder: See Section 4
------------------------------------------------- -------------------
11. Number of voting rights proxy
holder will cease
to hold:
------------------------------------------------- -------------------
12. Date on which proxy holder will
cease to hold
voting rights:
------------------------------------------------- -------------------
Figures are based on a total
13. Additional information: number of voting rights of
74,156,188 as per the Company's
'Conversion of Convertible
Loan Notes' announcement
of 18(th) April 2017.
** Although not reportable,
as per DTR5.1.5,the non-disclosable
(indirect) position is currently
865,438 shares, and is included
here in the interests of
transparency.
------------------------------- -------------------------------------
14. Contact name: Neil Whittaker, Aviva plc
------------------------------- -------------------------------------
15. Contact telephone number: 01603 684420
------------------------------- -------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUOUURBNAVRAR
(END) Dow Jones Newswires
May 03, 2017 08:29 ET (12:29 GMT)
Aviva (LSE:AV.)
Historical Stock Chart
From Aug 2024 to Sep 2024
Aviva (LSE:AV.)
Historical Stock Chart
From Sep 2023 to Sep 2024
